Table of Contents
Executive Summary — 5
SWOT
Analysis — 6
Kuwait Pharmaceuticals And Healthcare
Industry SWOT — 6
Kuwait Political
SWOT — 7
Kuwait Economic SWOT — 8
Kuwait Business Environment SWOT — 9
Pharmaceutical
Business Environment Ratings — 10
Table: Regional Business
Environment Ratings, Q309 — 10
Limits Of Potential
Returns — 11
Risks To Realisation Of
Returns — 11
Kuwait – Market
Summary — 13
Regulatory Regime — 14
Foreign Direct Investment Regulations — 15
Intellectual
Property Regime — 15
IP
Shortcomings — 16
Pricing And Reimbursement
Regime — 16
Public Procurement Of
Medicines — 18
Regional
Harmonisation — 18
Free Trade
Agreements — 19
Industry
Developments — 21
Epidemiology — 21
Healthcare Sector — 23
Primary
Care — 24
Secondary Care — 24
Recent
Public Health Developments — 25
Healthcare
Insurance — 26
Healthcare Reforms — 27
Regional Developments — 28
International
Collaboration — 29
Pharmaceutical
Sector — 30
Research And
Development — 31
Biotechnology
Sector — 32
Medical Devices — 32
Table: Diverse Potential For Product Launches: New Products For
2009 — 34
Industry Forecast
Scenario — 35
Overall Market
Forecasts — 35
Table: Kuwait – Drug Expenditure
Indicators, — 36
Key Growth Factors –
Industry — 37
Table: Kuwait – Health Expenditure
Indicators — 38
Key Growth Factors –
Macroeconomic — 39
Table: Kuwait – Economic
Activity, 2006-2013 — 42
Prescription Drug Market
Forecast — 43
Table: Kuwait - Prescription Market
Indicators, Historical Data And Forecasts (KWDmn unless otherwise
stated) — 44
Patented Drug Market
Forecast — 45
Table: Kuwait – Patented Market
Indicators — 46
Generic Drug Market
Forecast — 47
Table: Kuwait – Generics Market
Indicators, Historical Data And Forecasts — 48
OTC Drug
Market Forecast — 49
Table: Kuwait – OTC Market
Indicators, Historical Data And Forecasts (KWDmn unless otherwise
stated) — 50
Export/Import Drug Market
Forecasts — 51
Table: Kuwait – Pharmaceutical Trade
Indicators, Historical Data And Forecasts (US$mn unless otherwise
stated) — 52
Medical Devices
Forecast — 53
Table: Kuwait’s Medical Devices
Market, 2003-2013 — 54
Other Healthcare
Data — 55
Table: Kuwait – Other Healthcare
Indicators, Historical Data And Forecasts, 2003-2013 — 55
Key Risks To BMI Forecasts — 56
Competitive
Landscape — 57
Company Profiles — 58
Multinationals — 58
Novartis — 58
Sanofi-Aventis — 60
Pfizer — 61
GlaxoSmithKline — 62
Merck & Co — 63
Johnson & Johnson — 64
Indigenous
Players — 66
Advanced Technology
Company — 66
Bader Sultan & Bros — 68
Safwan Trading And Contracting Company — 70
Country
Snapshot: Kuwait Demographic Data — 71
Section 1:
Population — 71
Table: Demographic Indicators,
2005-2030 — 71
Table: Rural/Urban Breakdown,
2005-2030 — 72
Section 2: Education And
Healthcare — 72
Table: Education,
2002-2005 — 72
Table: Vital Statistics,
2005-2030 — 72
Section 3: Labour Market And Spending
Power — 73
Table: Employment Indicators,
1997-2006 — 73
Table: Consumer Expenditure,
2000-2012 — 73
BMI Forecast
Modelling — 74
How We Generate Our Pharmaceutical Industry
Forecasts — 74
Pharmaceutical Business Environment Ratings
Methodology — 75
Ratings Overview — 75
Table: Pharmaceutical Business Environment Indicators — 76
Weighting — 77
Table: Weighting Of
Components — 77
Sources — 77
| 
View Cart
